Home / Recalls / Wise Pharmacy / D-1570-2019

D-1570-2019 Class II Terminated

Recalled by Wise Pharmacy — Littleton, CO

FDA drug recall D-1570-2019 was initiated by Wise Pharmacy on July 22, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls The recall status is terminated (terminated February 3, 2020). Affected quantity: 1 container.

Recall Details

Product Type: Drugs
Report Date: August 7, 2019
Initiation Date: July 22, 2019
Termination Date: February 3, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1 container

Product Description

Gentamicin (GU) Irrigation 240 mg/500 mL Solution, 250 mL Container, Shake well and Refrigerate, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.

Reason for Recall

Lack of Processing Controls

Distribution Pattern

CO, TX, WY

Code Information

Lot #: 7179N, Exp 7/16/2019

Other recalls by Wise Pharmacy

D-1572-2019 Class II — Papaverine/Phentolamine 30 mg/1 mg/mL Injectable, 2.5 mL Vial, Rx only, Compound (July 22, 2019)
D-1571-2019 Class II — Tobramycin Irrigation 80 mg/1000 mL Solution, 1000 mL Container, Refrigerate, Na (July 22, 2019)
D-1576-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/50 mcg/mL Injectable, 2.5 mL Vial (July 22, 2019)
D-1573-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/0.2 mg/10 mcg/mL Injectable, 2.5 mL Vi (July 22, 2019)
D-1574-2019 Class II — Papaverine/Phentolamine/Alprostadil - 30 mg/1 mg/10 mcg/mL Injectable, 2.5 mL Vi (July 22, 2019)
D-1568-2019 Class II — Alprostadil 100 mcg/mL Injectable, 2.5 mL vial, Rx only, Compounded by Wise Phar (July 22, 2019)
D-1567-2019 Class II — Acetylcysteine 2% Otic Drop, 15 mL bottle, Rx only, Refrigerate, Compounded by W (July 22, 2019)
D-1569-2019 Class II — Dexamethasone Sodium Phosphate PF 24 mg/mL Injection, Refrigerate, Single Use Vi (July 22, 2019)
D-1575-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/30 mcg/mL Injectable, 2.5 mL Vial (July 22, 2019)
D-1577-2019 Class II — Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Inject (July 22, 2019)